Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

HOYA Corporation HOCPY OTC

Other OTC • Healthcare • Medical - Instruments & Supplies • JP • USD

SharesGrow Score
79/100
6/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

HOYA Corporation (HOCPY) — Analyst outlook / Analyst consensus target is. Based on 1 analyst ratings, the consensus is neutral — 1 Hold.

HOCPY Analyst Ratings

Hold
1
Ratings
1 Hold
Based on 1 analysts giving stock ratings to HOYA Corporation in the past 3 months
Rating breakdown
Hold
1 100%
0%
Buy
0 analysts
100%
Hold
1 analysts
0%
Sell
0 analysts

People Also View

ESLOY
ESLOY
EssilorLuxottica SA
$120.76
+3.72%
 ESLOF
ESLOF
EssilorLuxottica SA
$239.28
+4.06%
 BDX
BDX
Becton, Dickinson and Company
$155.73
+0.19%
 SAUHY
SAUHY
Straumann Holding AG
$11.16
+3.38%
 CLPBY
CLPBY
Coloplast A/S
$6.76
+0.90%
 CLPBF
CLPBF
Coloplast A/S
$65.31
+0.00%
 SSMXY
SSMXY
Sysmex Corporation
$8.82
+0.68%
 ANSLY
ANSLY
Ansell Limited
$83.53
+0.00%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message